stockrow
Monday 9 November 2026
Export PRQR’s income statement to Excel — free account
ProQR Therapeutics N.V.
PRQRProQR Therapeutics N.V.’s revenue for fiscal 2025 (year ended December 2025) was $18.0 million, down 12.0% from fiscal 2024.
- Revenue
- +135.0%
- EPS
- +28.6%
- Free cash flow
- −1.06%
- Total debt
- +8.71%
Quarter to June 2026, against a year earlier
1.35
0.02
+1.50%
Follow PRQR
Alert me
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
+8 more quarters Free account |
124.94 | 104.56 | 94.91 | 136.18 |
Receivables |
— | 7.69 | 5.15 | 4.54 | |
Other current assets |
0.67 | 1.03 | 1.74 | 0.69 | |
Total current assets |
130.13 | 113.28 | 101.80 | 141.42 | |
Property, Plant, Equpment (Net) |
15.22 | 14.29 | 14.11 | 13.86 | |
Total non-current assets |
15.22 | 14.29 | 14.11 | 13.86 | |
Total Assets |
145.35 | 127.57 | 115.91 | 155.28 | |
Accounts Payable |
0.36 | 0.34 | 0.22 | — | |
Current Part of Debt |
5.61 | 5.51 | 5.79 | 5.83 | |
Current Revenue (Deferred) |
20.33 | 19.86 | 22.95 | 20.51 | |
Other current liabilities |
10.48 | 9.25 | 10.07 | 12.34 | |
Total current liabilities |
38.73 | 36.70 | 41.03 | 40.55 | |
Non-current Revenue (Deferred) |
28.20 | 24.21 | 20.26 | 12.22 | |
Total non-current liabilities |
39.91 | 35.01 | 30.87 | 22.33 | |
Total liabilities |
78.64 | 71.71 | 71.90 | 62.87 | |
Additional Paid In Capital |
565.61 | 547.46 | 566.33 | 618.15 | |
Common Stock (Net) |
5.04 | 4.87 | 5.04 | 6.67 | |
Retained Earnings |
(536.18) | (528.94) | (560.50) | (566.71) | |
Shareholders Equity (Other) |
32.25 | 32.46 | 33.13 | 34.30 | |
Common Equity (Total) |
66.71 | 55.86 | 44.00 | 92.41 | |
Shareholders Equity (Total) |
66.71 | 55.86 | 44.00 | 92.41 | |
Shareholders Equity and Liabilities (Total) |
145.35 | 127.57 | 115.91 | 155.28 | |
Shares (Common) |
107.71 | 105.36 | 107.71 | 143.47 | |
Shareholders Equity (Tangible) |
66.71 | 55.86 | 44.00 | 92.41 | |
Net Debt |
(119.32) | (99.04) | (89.12) | (130.35) | |
Total Debt |
5.61 | 5.51 | 5.79 | 5.83 |
In millions of $ except per-share values · columns are period end dates